Enavate Sciences
Overview
Enavate Sciences is a private investment firm focused on supporting the strategic growth of innovative therapeutic and enabling technology companies in the healthcare sector. The firm provides significant capital and strategic growth support to companies developing novel therapies with the potential to transform patient care and improve quality of life. Enavate Sciences considers a broad range of therapeutic areas, prioritizing growth potential and addressing unmet medical needs. The firm's investment strategy encompasses various stages of company development, including early-stage, growth, and late-stage investments. Enavate Sciences has a particular emphasis on the biotechnology and pharmaceutical industries, aiming to empower a diverse portfolio of companies to accelerate innovation. The firm operates primarily within the United States, aligning with its mission to enhance healthcare outcomes through strategic investments. Enavate Sciences is led by CEO James Boylan, an experienced healthcare executive with nearly three decades in the life sciences sector. The firm's leadership team includes professionals with expertise in company building, drug discovery and development, clinical and market assessments, and comprehensive business development. This diverse team collaborates to ensure that each partner company realizes its full potential, contributing to advancements in patient care and therapeutic innovation.
Portfolio Companies
Reach Enavate Sciences directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Enavate Sciences
What sectors does Enavate Sciences invest in?
Enavate Sciences invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in New York, United States. Enavate Sciences is listed as a private investment firm in the ConnectSafely investor database.
What stage does Enavate Sciences invest at?
Enavate Sciences backs companies at Early Stage, Growth and Late Stage.
Which regions does Enavate Sciences invest in?
Enavate Sciences invests across United States.
Who are the partners at Enavate Sciences?
Team members listed for Enavate Sciences include James Boylan (Chief Executive Officer) and Edd Fleming (Executive Vice President, Commercialization).
What companies has Enavate Sciences invested in?
Enavate Sciences's portfolio includes Aviceda Therapeutics, Upstream Bio, Compass Therapeutics, Zenas BioPharma Inc, Normunity, BridgeBio Oncology Therapeutics and Sudo Biosciences.
How do I contact Enavate Sciences?
Enavate Sciences's contact details are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
